(Q34132829)

31 July 2017

0 references

Use of selective serotonin reuptake inhibitors and risk of fracture: a systematic review and meta-analysis (English)

1 reference

31 July 2017

0 references

0 references

1 reference

1 reference

Chun-Sick Eom

1

1 reference

31 July 2017

Hyun-Ki Lee

2

1 reference

31 July 2017

Sungmin Ye

3

1 reference

31 July 2017

Sang Min Park

4

1 reference

31 July 2017

Kyung-Hwan Cho

5

1 reference

31 July 2017

1 May 2012

1 reference

Journal of Bone and Mineral Research

31 July 2017

1 reference

31 July 2017

27

1 reference

31 July 2017

5

1 reference

31 July 2017

1186-1195

1 reference

Use of acid-suppressive drugs and risk of fracture: a meta-analysis of observational studies.

31 July 2017

1 reference

Use of acid-suppressive drugs and risk of pneumonia: a systematic review and meta-analysis

21 January 2018

1 reference

SSRIs, bone mineral density, and risk of fractures--a review

21 January 2018

1 reference

Use of antidepressants and rates of hip bone loss in older women: the study of osteoporotic fractures

21 January 2018

1 reference

Osteoporosis and its management

21 January 2018

1 reference

Epidemiology and outcomes of osteoporotic fractures

21 January 2018

1 reference

Incidence and economic burden of osteoporosis-related fractures in the United States, 2005-2025.

21 January 2018

1 reference

Diagnosis and treatment of depression in late life. Consensus statement update

21 January 2018

1 reference

Fortnightly review: drug treatment of depression

21 January 2018

1 reference

Predictors of Non-Spine Fracture in Elderly Men: The MrOS Study

21 January 2018

1 reference

Use of antidepressant drugs and risk of osteoporotic and non-osteoporotic fractures

21 January 2018

1 reference

Use of anti-depressants and the risk of fracture of the hip or femur.

21 January 2018

1 reference

Mapping the prescriptiome to fractures in men--a national analysis of prescription history and fracture risk

21 January 2018

1 reference

Fracture risk from psychotropic medications: a population-based analysis.

21 January 2018

1 reference

Selective serotonin reuptake inhibiting antidepressants are associated with an increased risk of nonvertebral fractures

21 January 2018

1 reference

Depressive symptoms, bone loss, and fractures in postmenopausal women

21 January 2018

1 reference

The epidemiology of fractures in England.

21 January 2018

1 reference

Effect of selective serotonin reuptake inhibitors on the risk of fracture

21 January 2018

1 reference

Exposure to tricyclic and selective serotonin reuptake inhibitor antidepressants and the risk of hip fracture

21 January 2018

1 reference

Use of selective serotonin-reuptake inhibitors or tricyclic antidepressants and risk of hip fractures in elderly people.

21 January 2018

1 reference

Neural regulation of bone and the skeletal effects of serotonin (5-hydroxytryptamine).

21 January 2018

1 reference

Assessment of fracture risk

21 January 2018

1 reference

Depression, fracture risk, and bone loss: a meta-analysis of cohort studies

21 January 2018

1 reference

Depression and hip fracture risk: the NHANES I epidemiologic follow-up study

21 January 2018

1 reference

Measuring inconsistency in meta-analyses

21 January 2018

1 reference

Meta-analysis in clinical trials

21 January 2018

1 reference

Central nervous system active medications and risk for fractures in older women

21 January 2018

1 reference

Selective serotonin-reuptake inhibitor antidepressants increase the risk of falls and hip fractures in elderly people by inhibiting cardiovascular ion channels

21 January 2018

1 reference

Risk of fractures with selective serotonin-reuptake inhibitors or tricyclic antidepressants

21 January 2018

1 reference

Serum levels and cardiovascular effects of tricyclic antidepressants and selective serotonin reuptake inhibitors in depressed patients

21 January 2018

1 reference

Expression of serotonin receptors in bone

21 January 2018

1 reference

Neurotransmitter action in osteoblasts: expression of a functional system for serotonin receptor activation and reuptake

21 January 2018

1 reference

Serotonin regulates osteoclast differentiation through its transporter

21 January 2018

1 reference

Serotonin transporter and receptor expression in osteocytic MLO-Y4 cells

21 January 2018

1 reference

Lrp5 controls bone formation by inhibiting serotonin synthesis in the duodenum

21 January 2018

1 reference

Serotonin and fluoxetine modulate bone cell function in vitro

21 January 2018

1 reference

Association of low bone mineral density with selective serotonin reuptake inhibitor use by older men.

21 January 2018

1 reference

Factors associated with the lumbar spine and proximal femur bone mineral density in older men.

21 January 2018

1 reference

Selective serotonin reuptake inhibitor use and bone mineral density in women with a history of depression

21 January 2018

1 reference

Bone mineral density in women with depression.

21 January 2018

1 reference

World-wide projections for hip fracture

21 January 2018

1 reference

The incidence of hip fracture in Europe.

21 January 2018

1 reference

21 January 2018

1 reference

21 January 2018

Identifiers

DOI

10.1002/JBMR.1554

1 reference

31 July 2017

1 reference